• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自分泌血管内皮生长因子 (VEGF) 在非小细胞肺癌细胞系 A549 中的作用。

Effects of autocrine vascular endothelial growth factor (VEGF) in non-small cell lung cancer cell line A549.

机构信息

Department of Geriatrics, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China.

出版信息

Mol Biol Rep. 2013 Apr;40(4):3093-9. doi: 10.1007/s11033-012-2383-4. Epub 2013 Mar 4.

DOI:10.1007/s11033-012-2383-4
PMID:23459872
Abstract

It is reported that the autocrine loop of the vascular endothelial growth factor (VEGF) is crucial for the survival and proliferation of non-small cell lung cancer (NSCLC) tumors. In this study we aimed to systematically investigate the role of autocrine vascular VEGF in NSCLC cell line A549 through inhibition of endogenous VEGF. A549 cells were transfected with florescence-labeled VEGF oligodeoxynucleotide with lipofectamine. For the experimental group, cells were transfected with VEGF anti-sense oligodeoxynucleotide (ASODN), sense oligodeoxynucleotide (SODN) and mutant oligodeoxynuleotide (MODN) respectively. For the control group cells were mock transfected with lipofectamine or culture medium. At indicated time point after transfection, the expression levels of VEGF mRNA and protein in A549 cells were analyzed by RT-PCR and ELISA respectively. Cell viability was measured by the MTT assay. Cell cycle distribution was detected by flow cytometry. As revealed by RT-PCR assay, the mRNA level of VEGF in cells transfected with ASDON was significantly lower than the other four groups (P < 0.05) at 24 and 48 h after transfection. ELISA assay yielded similar result with significantly decreased level of VEGF protein expression (P < 0.05). The survival fraction of A549 cells transfected with ASDON was significantly lower than the other four groups (P < 0.05) at 24 h after transfection. Also the percentage of G2 phase cells of ASODN group was significantly lower than other four groups. Our data indicate that VEGF expression is efficiently inhibited in A549 cells by ASODN transfection and this inhibition leads to inhibited cell growth and impaired cell cycle distribution.

摘要

据报道,血管内皮生长因子(VEGF)的自分泌环对于非小细胞肺癌(NSCLC)肿瘤的存活和增殖至关重要。在这项研究中,我们旨在通过抑制内源性 VEGF 来系统地研究自分泌血管 VEGF 在 NSCLC 细胞系 A549 中的作用。使用脂质体将荧光标记的 VEGF 寡核苷酸转染到 A549 细胞中。对于实验组,分别用 VEGF 反义寡核苷酸(ASODN)、正义寡核苷酸(SODN)和突变寡核苷酸(MODN)转染细胞。对于对照组,细胞用脂质体或培养基模拟转染。转染后指定时间点,通过 RT-PCR 和 ELISA 分别分析 A549 细胞中 VEGF mRNA 和蛋白的表达水平。通过 MTT 测定法测量细胞活力。通过流式细胞术检测细胞周期分布。RT-PCR 检测结果显示,转染 ASDON 的细胞中 VEGF mRNA 的水平在转染后 24 和 48 小时显着低于其他四组(P <0.05)。ELISA 检测也得到了相似的结果,VEGF 蛋白表达水平显着降低(P <0.05)。转染 ASDON 的 A549 细胞的存活分数显着低于其他四组(P <0.05)。ASODN 组的 G2 期细胞百分比也显着低于其他四组。我们的数据表明,ASODN 转染可有效抑制 A549 细胞中 VEGF 的表达,从而抑制细胞生长和受损的细胞周期分布。

相似文献

1
Effects of autocrine vascular endothelial growth factor (VEGF) in non-small cell lung cancer cell line A549.自分泌血管内皮生长因子 (VEGF) 在非小细胞肺癌细胞系 A549 中的作用。
Mol Biol Rep. 2013 Apr;40(4):3093-9. doi: 10.1007/s11033-012-2383-4. Epub 2013 Mar 4.
2
[Effects of vascular endothelial growth factor (VEGF) antisense oligodeoxynucleotide on mRNA and expression of VEGF, flt-1, and kinase insert domain containing receptor and VEGF excretion in human gallbladder carcinoma cells].血管内皮生长因子(VEGF)反义寡脱氧核苷酸对人胆囊癌细胞中VEGF、flt-1、含激酶插入结构域受体的mRNA及表达以及VEGF排泄的影响
Zhonghua Yi Xue Za Zhi. 2007 Dec 18;87(47):3329-34.
3
[shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].[短发夹RNA介导的胰岛素样生长因子I受体基因沉默抑制非小细胞肺癌细胞增殖、诱导细胞凋亡并抑制肿瘤生长:体内外实验]
Zhonghua Yi Xue Za Zhi. 2007 Jun 5;87(21):1506-9.
4
Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.微小RNA-135a通过IGF-1/PI3K/Akt信号通路对非小细胞肺癌细胞增殖、迁移、侵袭、凋亡及肿瘤血管生成的影响
Cell Physiol Biochem. 2017;42(4):1431-1446. doi: 10.1159/000479207. Epub 2017 Jul 17.
5
[The inhibitory effect of vascular endothelial growth factor antisense oligonucleotides in angiogenesis of thyroid carcinoma].血管内皮生长因子反义寡核苷酸对甲状腺癌血管生成的抑制作用
Zhonghua Nei Ke Za Zhi. 2005 Apr;44(4):280-4.
6
Expression of HAb18G in non-small lung cancer and characterization of activation, migration, proliferation, and apoptosis in A549 cells following siRNA-induced downregulation of HAb18G.HAb18G 在非小细胞肺癌中的表达及 siRNA 下调 HAb18G 后 A549 细胞的激活、迁移、增殖和凋亡的特征。
Mol Cell Biochem. 2013 Nov;383(1-2):1-11. doi: 10.1007/s11010-013-1722-7. Epub 2013 Sep 8.
7
Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer.血管内皮生长因子是一种自分泌生长因子,在非小细胞肺癌中通过神经纤毛蛋白-1发出信号。
Mol Cancer. 2015 Feb 20;14:45. doi: 10.1186/s12943-015-0310-8.
8
Effects of exogenous VEGF(165)b on invasion and migration of human lung adenocarcinoma A549 cells.外源性VEGF(165)b对人肺腺癌A549细胞侵袭和迁移的影响。
J Huazhong Univ Sci Technolog Med Sci. 2011 Oct;31(5):619. doi: 10.1007/s11596-011-0571-4. Epub 2011 Oct 25.
9
[Effect of down-regulation of survivin gene on apoptosis and cisplatin resistance in cisplatin resistant human lung adenocarcinoma A549/CDDP cells].[生存素基因下调对顺铂耐药人肺腺癌A549/CDDP细胞凋亡及顺铂耐药性的影响]
Zhonghua Zhong Liu Za Zhi. 2006 Jun;28(6):408-12.
10
[Effect of inhabitation of VEGF expression with RNA interference on lung cancer therapy].[RNA干扰抑制VEGF表达对肺癌治疗的影响]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009 Apr;25(4):341-3, 347.

引用本文的文献

1
Keratinocyte-derived VEGF-A is an essential pro-migratory autocrine mediator, acting through the KDR/GEF-H1/RhoA pathway.角质形成细胞衍生的血管内皮生长因子A(VEGF-A)是一种重要的促迁移自分泌介质,通过KDR/GEF-H1/RhoA途径发挥作用。
Front Cell Dev Biol. 2025 Jul 17;13:1601887. doi: 10.3389/fcell.2025.1601887. eCollection 2025.
2
Suppressing VEGF-A/VEGFR-2 Signaling Contributes to the Anti-Angiogenic Effects of PPE8, a Novel Naphthoquinone-Based Compound.抑制 VEGF-A/VEGFR-2 信号通路有助于新型萘醌类化合物 PPE8 的抗血管生成作用。
Cells. 2022 Jul 5;11(13):2114. doi: 10.3390/cells11132114.
3
Anti-Angiogenetic and Anti-Lymphangiogenic Effects of a Novel 2-Aminobenzimidazole Derivative, MFB.

本文引用的文献

1
RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.RNAi 介导的 VEGF-C 沉默通过同时下调 CXCR4、CCR7、VEGFR-2 和 VEGFR-3 依赖性轴诱导的 ERK、p38 和 AKT 信号通路抑制非小细胞肺癌的进展。
Eur J Cancer. 2011 Oct;47(15):2353-63. doi: 10.1016/j.ejca.2011.05.006. Epub 2011 Jun 15.
2
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
3
Targeted therapies for non-small cell lung cancer: an evolving landscape.
新型2-氨基苯并咪唑衍生物MFB的抗血管生成和抗淋巴管生成作用
Front Oncol. 2022 Jun 20;12:862326. doi: 10.3389/fonc.2022.862326. eCollection 2022.
4
p18, a novel adaptor protein, regulates pulmonary endothelial barrier function via enhanced endocytic recycling of VE-cadherin.p18是一种新型衔接蛋白,通过增强血管内皮钙黏蛋白的内吞再循环来调节肺内皮屏障功能。
FASEB J. 2015 Mar;29(3):868-81. doi: 10.1096/fj.14-257212. Epub 2014 Nov 17.
5
Nonsmall cell lung cancer therapy: insight into multitargeted small-molecule growth factor receptor inhibitors.非小细胞肺癌治疗:多靶点小分子生长因子受体抑制剂的研究进展。
Biomed Res Int. 2013;2013:964743. doi: 10.1155/2013/964743. Epub 2013 Jul 1.
非小细胞肺癌的靶向治疗:不断变化的领域。
Mol Cancer Ther. 2010 Jul;9(7):1931-44. doi: 10.1158/1535-7163.MCT-10-0239. Epub 2010 Jun 22.
4
Efficient inhibition of non-small-cell lung cancer xenograft by systemic delivery of plasmid-encoding short-hairpin RNA targeting VEGF.系统递送靶向 VEGF 的短发夹 RNA 质粒有效抑制非小细胞肺癌异种移植瘤。
Cancer Biother Radiopharm. 2010 Feb;25(1):65-73. doi: 10.1089/cbr.2009.0692.
5
Targeted therapy for nonsmall cell lung cancer: focusing on angiogenesis, the epidermal growth factor receptor and multikinase inhibitors.非小细胞肺癌的靶向治疗:聚焦血管生成、表皮生长因子受体和多激酶抑制剂。
Anticancer Drugs. 2010 Feb;21(2):151-68. doi: 10.1097/CAD.0b013e328334da02.
6
First line chemotherapy with weekly docetaxel and cisplatin in elderly patients with advanced non-small cell lung cancer: a multicenter phase II study.多西他赛与顺铂每周方案一线化疗用于老年晚期非小细胞肺癌患者:一项多中心II期研究
J Thorac Oncol. 2009 Apr;4(4):512-7. doi: 10.1097/jto.0b013e3181991d38.
7
Tissue factor expression in non-small cell lung cancer: relationship with vascular endothelial growth factor expression, microvascular density, and K-ras mutation.非小细胞肺癌中组织因子的表达:与血管内皮生长因子表达、微血管密度及K-ras突变的关系
J Thorac Oncol. 2008 Jul;3(7):689-97. doi: 10.1097/JTO.0b013e31817c1b21.
8
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.过去30年美国小细胞肺癌流行病学的变化:监测、流行病学和最终结果数据库分析
J Clin Oncol. 2006 Oct 1;24(28):4539-44. doi: 10.1200/JCO.2005.04.4859.
9
Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter.吉西他滨和顺铂治疗复发晚期非小细胞肺癌:给药顺序很重要。
Cancer Chemother Pharmacol. 2007 Apr;59(5):621-9. doi: 10.1007/s00280-006-0304-8. Epub 2006 Aug 26.
10
Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF).血管内皮生长因子(VEGF)的血管生成及细胞存活功能
J Cell Mol Med. 2005 Oct-Dec;9(4):777-94. doi: 10.1111/j.1582-4934.2005.tb00379.x.